Navigation Links
New Vision Test Helps Detect Optic Nerve Diseases Including Glaucoma
Date:3/28/2011

PINE BROOK, N.J., March 28, 2011 /PRNewswire/ -- Diopsys, Inc. has launched the new Diopsys® NOVA-DN VEP Vision Testing System to help optometrists and ophthalmologists detect optic nerve disease, including glaucoma and other neuro-visual disorders.

Glaucoma is the second leading cause of blindness in the world, reports the World Health Organization. According to Prevent Blindness America, glaucoma is often called the "sneak thief of sight" because half of all patients who have it do not know it.  Many optic nerve disorders, such as glaucoma and ischemic optic neuropathy, are asymptomatic since central vision may not be affected until later stages of the disease. Also, diagnosis and management of optic nerve disorders are often based on structural or visual field tests which are limited in their ability to detect disease early.  

The Diopsys® NOVA-DN allows clinicians to objectively assess optic nerve disease earlier than traditional vision tests because it uses Visual Evoked Potential (VEP) technology and proprietary software to evaluate the entire vision system from the eye to the visual cortex. "VEP is an objective, functional test that can help discriminate between healthy and glaucomatous eyes," says Alberto Gonzalez Garcia, M.D., neuro-ophthalmologist and Research Director at Diopsys, Inc. Optometrists and ophthalmologists may use VEP in addition to traditional testing methods to enhance diagnosis and treatment.

The Diopsys® NOVA-DN records the electrical response of a patient's entire vision system and provides easy-to-read reports that give the doctor a simple way to evaluate optic nerve function.  Physicians are able to compare tests over time to track disease progression.

Dr. Fran Bucciero of Family Vision Care in Springfield, NJ, one of the first eye care professionals to have the device in his office says, "I've been using the Diopsys® NOVA-DN in my practice to help me diagnose glaucoma patients, and to track their disease progression. Because of the straightforward reports, I am able to show my patients how well their treatment is working which helps enormously with treatment compliance."  

Diopsys, Inc. (http://www.diopsys.com) is a medical instrumentation company dedicated to delivering high-quality, cost-effective preventative health care.  The company specializes in the development and marketing of patient-friendly, non-invasive diagnostic vision testing equipment.  Diopsys has developed and markets the patented Enfant® Pediatric Vision Testing System, a device used by pediatricians to test for visual deficits, including amblyopia, in children as young as six months of age. Diopsys also developed and markets the Diopsys® NOVA-DT (Diagnostic & Tracking), Diopsys® NOVA-TR (Transient Response) and Diopsys® NOVA-DN (Diseases of the Optic Nerve)  Vision Testing Systems utilized by ophthalmologists and optometrists for the detection, diagnosis and treatment of vision disorders.


'/>"/>
SOURCE Diopsys, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. In a Phase 2 Study PF-04523655 (RTP801I-14) Showed Improved Vision Over Standard of Care in Patients with Diabetic Macular Edema at 12 Months
2. CooperVision Introduces New Corporate Brand Identity
3. New Ad Campaign: Secret Provision Raises Taxes on Prescription Drug Benefits, Creates Conflict of Interest
4. Erica L. Mann, Former Pfizer Executive, Appointed New President of Bayer HealthCares Global Consumer Care Division
5. TLC Vision Announces TLC Laser Eye Center San Diego
6. Life Technologies Announces Visionary Winners of the Ion Torrent PGM Grants Program in Europe
7. New Clinical Study Shows RyMed InVision-Plus® IV Connector Dramatically Reduced Catheter-Related Bloodstream Infections by Over 92%
8. Sevocity, a Division of Conceptual MindWorks, Incs Sevocity Receives ONC-ATCB 2011/2012 Certification
9. HealthWarehouse.com Acquires Online Division of Hocks Pharmacy
10. Rock Creek Pharmaceuticals Discloses Filing of Provisional Patent Application For Isolated Anatabine Isomer
11. Elka Nir Joins VisionCare Board of Directors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/4/2017)... , Aug. 3, 2017  Agragen, LLC, a ... active in the biopharmaceutical, nutraceutical, and aquacultural feed ... of its lead drug candidates, AGR131.  This drug ... cytokine from the blood of patients suffering from ... inflammatory bowel disease. ...
(Date:8/2/2017)... , Aug. 2, 2017 Fenita ... Who as a Pinnacle Lifetime Professional in the ... Account Manager at Turing Pharmaceuticals, AG. Her skills ... and relationship building.                ... than 25 years of experience as a highly ...
(Date:8/2/2017)...  Life Flight Network and PeaceHealth Oregon Network announced they ... and operational efficiency for patients at hospitals in ... Cottage Grove , and Florence, Oregon ... Flight Network work collaboratively to move patients who require the ... time sensitive emergency exists. ...
Breaking Medicine Technology:
(Date:8/23/2017)... ... August 23, 2017 , ... CEFEX, ... as adhering to the standards representing best practices in the retirement plan industry. ... practice standard and helps to verify that NFP’s retirement division focuses on putting ...
(Date:8/23/2017)... ... 2017 , ... Arizona Spine & Joint Hospital http://www.azspineandjoint.com ... of High Performing Hospitals by U.S. News & World Report for knee replacement in ... better than the national average in a given procedure or condition.  , A ...
(Date:8/23/2017)... ... 23, 2017 , ... TSC Advantage has been awarded Gold ... Solution Innovations and Security Solution for Government Innovations. Both gold awards recognize TSC ... DHS SAFETY Act-designated enterprise security assessment approach. , The ninth annual Golden Bridge ...
(Date:8/22/2017)... ... August 22, 2017 , ... ... good health is as simple as eating healthy foods. But this well-known piece ... fat, making insulin, or breaking apart carbohydrates—depends not only on properties of the ...
(Date:8/22/2017)... Westerly, RI (PRWEB) , ... August 22, 2017 , ... ... on five acres at picturesque Babcock Cove, recently received training and certification in ... Hill , which has a prestigious five-star rating from the Centers for Medicare and ...
Breaking Medicine News(10 mins):